CONTEXT: Despite the headline news that RWE shows no real improvement for mesothelioma patients, if you get down to the end of the article, there is promising news with the first new treatment approval from the FDA in 16 years for a combination therapy | Canadian data only.
IMPACT: Medium
READ TIME: 2 mins
Quality Level Mean [1 – 10]: 8
1. “No Marked Improvement in Overall Mesothelioma Survival. The one-institution, retrospective study involved 337 patients from 1991 to 2019 who were diagnosed and treated for pleural mesothelioma.”
2. “Despite clinical trials that often produce inflated expectations, real-world survival rates for pleural mesothelioma have failed to advance significantly over the past three decades, according to one recent study in Canada.”
3. “Wheatley-Price co-authored the recent study tracking nearly 30 years of pleural mesothelioma patients at the well-respected Ottawa Hospital Cancer Centre in Canada’s capital city.”
4. “The lack of significant survival improvement through the years could be explained, at least partially, by a higher percentage of patients with the toughest-to-treat subtype of mesothelioma – sarcomatoid – in the third decade.”
5. “The indwelling pleural catheters, which have emerged as a convenient treatment for pleural effusions that accompany mesothelioma, were used in almost half of the patients treated in the third decade of the study.”
Source URL: https://www.asbestos.com/news/2021/05/11/three-decades-mesothelioma-statistics/